2022
COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study
Poghosyan H, Ni Z, Vlahov D, Nelson L, Nam S. COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study. Journal Of Community Health 2022, 48: 315-324. PMID: 36427111, PMCID: PMC9702715, DOI: 10.1007/s10900-022-01174-5.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineCOVID-19 vaccine hesitancyCancer historyVaccine hesitancyMedicare beneficiariesVaccine uptakeMultivariable logistic regression modelCOVID-19 vaccine uptakeVaccine hesitancy ratesOngoing health conditionsCOVID-19 vaccinationLogistic regression modelsComplex survey designLack of recommendationsHesitancy ratesVaccine benefitsCommon reasonHesitant individualsSide effectsUS populationVaccineHealth conditionsCross-sectional dataHesitancyRegression models
2000
Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals
Kuo I, Fischer B, Vlahov D. Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals. International Journal Of Drug Policy 2000, 11: 357-370. PMID: 10967518, DOI: 10.1016/s0955-3959(00)00057-8.Peer-Reviewed Original ResearchMethadone treatmentMajor public health problemOpiate addictsAdditional treatment strategiesHeroin-assisted treatmentPrincipal treatment modalityPublic health problemOpiate-dependent individualsSubstance abuse treatmentTreatment modalitiesClinical trialsTreatment outcomesTreatment strategiesSide effectsEconomic burdenHealth problemsInjectable opiatesTreatment programAbuse treatmentTreatment participationEffective interventionsTreatmentPositive resultsAddictsRecent studies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply